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Free films of pullulan-polymethacrylate associations were produced by casting process to develop a novel 
target-specific material. For characterization, tests of water vapor permeability, swelling index, infrared 
absorption spectroscopy, thermogravimetric analysis, scanning electron microscopy and mechanical 
analysis were performed. The polysaccharide concentration directly influenced vapor permeability and 
swelling, increasing the values of the latter up to five times when added in a proportion of 20% (per 
weight). The individual properties of each polymer were maintained, and chemical interactions were not 
detected. The films were found to be thermally stable and they had unaltered mechanical properties with 
the addition of the polysaccharide. The microscopic analysis revealed rugosity that was proportional 
to pullulan and disorganization of the polymer network at pH 6.8. These results suggest that this novel 
material has potential for enteric drug release because of synergism between pH and enzyme dependence. 
Keywords: Films. Polymeric material. Modified release/enteric release/oral delivery/controlled release. 
Glucans. Eudragit. Physicochemical characterization.
INTRODUCTION
Despite patients’ acceptance and flexibility with 
regard to the concept of different methods of dosing, oral 
drug administration has some therapeutic limitations. 
Consequently, new formulations, such as modified release, 
have been proposed (Wasnik, Parmar, 2011). Release 
in distal regions of the gastrointestinal tract (GIT) is 
beneficial for the treatment of pathologies that affect the 
large intestine because the drug is released at the site of 
action, thus increasing the concentration of the drug at 
these regions, decreasing the ingested dose, and decreasing 
side effects (Freire et al., 2006; Nadler, Kam, Rubinstein, 
2010; Wasnik, Parmar, 2011; Shukla, Tiwari, 2012). 
Additionally, these target-specific systems are potentially 
adequate for the release of protein and peptide therapeutics 
and protection of their activity from hostile physiological 
conditions related to stomach pH and digestive enzymes 
(Freire et al., 2006; Pinto, 2010; Wen, Park, 2010; Wasnik, 
Parmar, 2011).
The polymethacrylate Eudragit® FS 30 D (EFS) is 
an aqueous dispersion at 30%, consisting of a copolymer 
of methylacrylate, methylmethacrylate, and methacrylic 
acid and possessing carboxylic acid as the functional group 
(Evonik, 2016). The dissolution of this synthetic polymer 
occurs via salt formation and water uptake in fluids at pH 
>7.0, which allows pH-dependent drug release (Dulin, 
2010; Evonik, 2016). Therefore, EFS, when used as a 
coating in reservoir or in matrix systems, passes through 
the stomach and small intestine intact and is dissolved 
only when it contacts neutral-to-alkaline pH in the colonic 
segment (Ibekwe et al., 2006).
However, these systems do not always accomplish 
the goal of efficacious drug release at the desired site. 
Some pathologies cause colon pH to undergo extreme 
variations (e.g., in inflammatory illness, such as ulcerative 
colitis and Crohn’s disease) when the pH can change in 
the range of 4.7 to 2.3 (Freire et al., 2006; Nadler, Kam, 
Rubinstein, 2010; Rabito et al., 2012). This reduction is 
attributable to fermentation processes in the region (Nadler, 
Kam, Rubinstein, 2010). Moreover, coatings for colonic 
release that are exclusively sensitive to pH can present low 
specificity because they depend on other factors, such as 
intestinal transit and coating thickness, for drug release. 
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Therefore, the drug is at risk of being prematurely released 
or causing undesired and slow availability in the descending 
colon (Nadler, Kam, Rubinstein, 2010; Wen, Park, 2010).
One way to overcome these issues of pH-dependent 
release systems is the association of the physiological 
mechanisms present in the GIT. One can combine 
strategies of applying materials destined for pH-related 
release with materials that are sensitive to microbiota 
biodegradation. Thus, upon reaching the colon, both 
strategies can act synergistically, leading to disintegration 
of the pharmaceutical form and working as a safety 
device with target-specific capacity (Ibekwe et al., 2008; 
Mcconnell, Short, Basit, 2008; Villanova, Oréfice, Cunha, 
2010; Basit, Mcconnell, 2011).
Pullulan (PU) is  a  natural  polymer that  is 
extracellularly produced by the fungus Aureobasidium 
pullulans, in starch and sugar cultures; therefore, it is 
considered an exopolysaccharide (Xiao, Lim, Tong, 2012). 
It is characterized as a a-glucan and has a linear primary 
structure composed of subunits of maltotriose linked by 
a-1,6-glycosidic linkages (Pradella, 2006; Introzzi et al., 
2012). This structure allows PU to have good solubility 
in water (Xiao, Lim, Tong, 2012).
This exopolysaccharide has no odor, taste, or toxicity. 
The molecular weight is between 8000 and 2 000 000 
Da, depending on the culture conditions and commercial 
application of PU (e.g., industrial, medical, and alimentary) 
(Pradella, 2006). Moreover, digestive enzymes in the human 
intestine do not degrade PU (Prajapati, Jani, Khanda, 
2013). However, it promotes the growth of intestinal 
Bifidobacterium spp and it can be considered a prebiotic 
(Silva et al., 2006). It can be used for modified drug release 
by acting as an enzyme-dependent polymer because it acts 
as a substrate for this ecosystem.
PU still presents adhesive properties and the 
capacity to form biodegradable and edible fibers and films 
(Cheng, Demirci, Catchmark, 2011). The films obtained 
from this exopolysaccharide are thermally stable, have 
elastic and antistatic properties, can be used for printing, 
and are directly compressible under heat and humidity. 
Additional characteristics include transparency, solubility 
in water, and insolubility in organic solvents. Furthermore, 
because of its filmogenic particularities, the addition of a 
plasticizer is not necessary (Singh, Saini, Kennedy, 2008; 
Islam, Yeum, Das, 2012; Wu et al., 2013).
To discover a convenient way to explore pH and 
enzyme-dependent synergistic properties, the goal of the 
present study was to develop a novel polymeric material 
destined for drug release in the distal part of the GIT by 
associating the polymethacrylate EFS and polysaccharide 
PU.
MATERIAL AND METHODS
Material
Alimentary-grade pullulan (CAS 9057-02-7; Tovani 
Benzaquem Ingredientes®, Brazil), Eudragit® FS 30 D (CAS 
26936-24-3; Evonik®, Germany), polysorbate 80, glyceryl 
monostearate, sodium chloride, hydrochloric acid, sodium 
hydroxide, monobasic potassium phosphate, and distilled 
water were used. All of the reagents had analytical purity.
Preparation of free films
The films were produced using a casting process, 
in which the aqueous dispersion of the synthetic polymer 
EFS was associated with the polysaccharide PU in varying 
mass proportions: 100:00, 95:05, 90:10, and 80:20 
respectively. 
Initially, the polymethacrylate EFS was shaken at 
50 ºC for 30 min with a 5% emulsion of the sliding glyceryl 
monostearate and wetting agent polysorbate 80 (2%) 
according to the methods proposed by Rabito et al. (2012) 
to obtain a homogeneous dispersion. Concomitantly, PU 
was dissolved in distilled water, heated at 50 ºC, and 
slowly added to the polymethacrylate dispersion. The 
final dispersion after total homogeneity was poured into 
Teflon molds in 10 ml samples and maintained in an oven 
at 50 ± 2 ºC for approximately 24 h. After complete solvent 
evaporation, the films were carefully removed from the 
molds and stored in desiccators that contained silica 
gel. For infrared testing, thermal behavior analysis, and 
mechanical analysis, films of 100% PU were also prepared. 
The final polymeric concentration was maintained at a 
constant 4% w/v for all of the formulations. 
The film thickness was determined using a Mitutoyo® 
micrometer with 0.01 mm precision. Five different points 
were measured in three samples of isolated films for each 
association. Statistical analysis was performed by means 
of Analysis of Variance using a confidence level of 95%. 
Water vapor transmission (WVT)
Method “B” (E 96-66) of the American Society for 
Testing and Materials (ASTM, 1966) was used to verify 
the films’ water vapor permeability. Films with an area 
of 10 cm² were fixed in Payne permeability cups (Braive 
Instruments) that contained 10 ml of distilled water, and 
the set was weighed at predetermined times (0, 24, 48, 72, 
96, and 120 h) until obtaining constant rate.
Tests were performed in triplicate, and the cups were 
stored in desiccators that contained dehydrated silica gel, 
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which was replaced at each weighing. From the mass loss, 
the rate of water vapor transmission was calculated using 
Equation 1 (Van Den Mooter, Samyn, Kinget, 1994):
 WVT = g x 24 / t x a  (Equation 1) 
where g is the mass loss (g), t is the time in hours during 
which the weights were monitored (h), and a is the film 
area (m²). 
Swelling index (Is%)
To evaluate the swelling index of the polymer 
materials, film samples were sliced with surgical scissors 
at approximately 1 cm². To remove any residual humidity, 
the samples were left in an oven at 50 ºC until reaching a 
constant weight. 
Each sample was weighed on an analytical scale to 
obtain the dry weight and immersed in simulated gastric 
fluid (SGF; pH 1.2) or simulated intestinal fluid (SIF; pH 
6.8) prepared according to the 35th edition of the United 
States Pharmacopeia (USP, 2011), but without the addition 
of enzyme. At each interval (10, 30, 60, 90, 120, 150, and 
180 min) (Ghaffari et al., 2007), the films were carefully 
removed from the immersion media, and the excess 
liquid was removed with filter paper. The samples were 
weighed again to determine hydration. The procedure was 
performed in triplicate. 
The films’ swelling indices (Is%) were established 
according to Equation 2, where Wd represents the film’s 
dry mass (g), and Ws represents the film’s mass after 
immersion (g). 
                  Is% = (Ws – Wd) x 100 / Wd  (Equation 2)
Fourier transform infrared spectroscopy (FTIR)
The infrared absorption spectroscopy assay was 
performed using the Attenuated Total Reflectance 
technique with 32 scans at a pressure of 530 pounds per 
square inch (psi) using an FTIR BOMEM–MB–100 
(Michelson®) spectrophotometer. 
Thermogravimetric analysis (TGA)
The thermal stability of the different compositions 
of polymeric films was evaluated using thermogravimetric 
analysis with a Simultaneous Thermal Analyzer STA 409 
PC Luxx (Netzsch®). Approximately 6 mg samples were 
previously dehydrated, entrapped in a Pt-Rd crucible, 
and subjected to an atmosphere with a 30 mL/min flow 
of nitrogen gas and increasing temperature of 22-900 °C 
at 10 °C/min. 
Characterization by Scanning electron 
microscopy
Morphological characterization was performed 
using scanning electron microscopy (SEM). The films 
were analyzed while drying and after swelling for 3 h 
in SGF (pH 1.2) and SIF (pH 6.8). After hydration, the 
pellicles were frozen at -18 °C to conserve their structures 
and then lyophilized at -55 °C for 6 h in a freeze drying 
Liotop® L101 (Liobras®). The samples were metallized 
with gold and surface micrographs were obtained with 
a Scanning Electron Microscope SS-550 SUPERSCAN 
(Shimadzu®) operated at 10 keV. 
Mechanical properties
According to the ASTM D882 method, mechanical 
analyses were performed with a texturometer TA.XT2 
(Stable Microsystems®) equipped with a 5 kg load cell in 
an environment with controlled temperature (25 ± 1 °C) 
and humidity (55 ± 3%).
The samples were cut into sizes of 50 mm × 15 
mm and adjusted to the equipment grips (Fajardo et al., 
2012). The parameters were the following: tension of 
rupture, maximum elongation, and Young’s modulus, 
directly determined by Exponent 6.1.1.0 software (Stable 
Microsystems®). Four samples of each association were 
analyzed, and the averages were calculated.
Statistical analysis
Analysis of variance for multiple comparisons 
were used to compare the values obtained with different 
proportions of EFS and PU. (Villanova, Oréfice, Cunha, 
2010; Xiao, Lim, Tong, 2012). Tukey’s test was used for 
posthoc comparisons of the different polymer associations 
(Bunhak et al., 2007; Rabito et al., 2012). Student’s t-test 
was used in the swelling index to compare the hydration 
between two fluids. The level of statistical significance 
was set at p < 0.05
RESULTS AND DISCUSSION
Morphological-macroscopic evaluation and film 
thickness
Films that had air bubbles, cracks, or deformities 
were discarded to avoid interference with the analysis. 
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With regard to opacity, transparency reduced as the 
polysaccharide concentration increased. The mean 
thickness was 0.11 ± 0.01 mm, and no significant 
differences were found among the samples that had 
different concentrations of synthetic and natural polymers 
(p>0.05). 
Water vapor transmission
Table I shows that water vapor permeability 
was proportional to PU concentration (p < 0.05). 
Cavalcanti et al. (2002) and Bunhak et al. (2007) also 
observed an increase in WVT when working with 
combinations of polymethacrylate and polysaccharides, 
like galactomannans and chondroitin sulfate respectively. 
This is mainly attributable to an increase in the system’s 
hydrophilicity produced by the natural polymer. However, 
the WVT obtained in the EFS:PU formulations were 
inferior to those resulting in the cited works, which 
represents an advantage, since there is a greater prevention 
of the premature release of drugs in the upper parts of the 
GIT.
Additionally, Figure 1 shows a linear relationship 
between the mass loss and time. Akhgari et al. (2006) 
obtained similar results working with EFS and inulin.
Swelling index
Figure 2 shows the swelling index obtained after 180 
min immersion in SGF and SIF. Statistical analysis was 
realized for the swelling index obtained in all the tested 
times of immersion (10, 30, 60, 90, 120, 150 and 180 min), 
and, after film immersion in SGF, significant differences 
(p<0.05) occurred in the samples with 100:00 and 90:10 
proportions and 100:00 and 80:20 proportions. For the 
films immersed in SIF, significant differences were found 
between films with 100:00 and 80:20 proportions and 95:5 
and 80:20 proportions. Because of the high hydrophilicity 
of the natural polymer, films with higher concentrations 
of PU presented higher levels of hydration. 
Notable are the results obtained with samples of 
free films with different associations immersed in pH 
6.8 (p<0.05; i.e., higher Is%). These findings suggest a 
predominance of EFS properties because they are pH-
dependent and soluble in neutral and slightly alkaline 
pH. In SIF, this polymer naturally ionized, absorbing 
large amounts of solvent. Akhgari et al. (2006) previously 
reported this phenomenon and attributed it to the 
characteristics of the base synthetic polymer.
Akhgari et al.  (2006) working with various 
combinations of EFS and inulin, obtained Is% similar to 
those obtained for the EFS:PU formulations. However, as 
for the WVT assay, the swelling values in SGF found in the 
present study were lower, demonstrating a greater resistance 
to premature drug release in the upper regions of the GIT.
Infrared absorption spectroscopy
Figure 3 shows that both EFS and PU presented 
bands in regions similar to the ones reported in the 
literature. The film that contained only EFS displayed a 
spectrum with bands at 1161 cm-1 and 1194 cm-1 due to 
FIGURE 1 – Mass loss for films prepared at different EFS:PU 
ratios (n=3).
TABLE I - Values of mass loss and water vapor transmission (n=3). Means in a column with different superscripts (a - c) are 
significantly different (p<0.05, by Tukey’s test)
Polymer association WVT  (g/m2 24h)
Values of mass loss  
(g/120h)
EFS 100:00 PU 170.69 ± 20.55a 0.85 ± 0.10
EFS 95:05 PU 234.65 ± 23.56b 1.17 ± 0.12
EFS 90:10 PU 263.19 ± 18.72b 1.32 ± 0.09
EFS 80:20 PU 550.67 ± 11.64c 2.75 ± 0.06
Development and characterization of pullulan-polymethacrylate free films as potential material for enteric drug release
Braz. J. Pharm. Sci. 2017;53(3):e00002 Page 5 / 9
ester vibrations, a band at 1728 cm-1 that corresponded 
to vibrations of C=O of esterified carboxyl groups, and 
bands at 2900-3000 cm-1, 1387 cm-1, and 1437 cm-1 due to 
vibrations of CHx (Evonik, 2016; Moustafine et al., 2012).
The spectroscopy of PU showed bands at 3331 cm-1 
that corresponded to repeated units of hydroxyl groups, 
2926 cm-1 due to vibrations of C-H linkages, 1641 cm-1 
caused by C-O-C linkages, 1358 cm-1 caused by C-O-H 
linkages, 1148 cm-1 caused by C-O-C linkages, 1012 cm-1 
caused by C-O linkages, 754 cm-1 that demonstrates the 
linkages predominant in PU between glucose units a-(1,4) 
and a-(1,6), 932 cm-1 related to the presence of glycosidic 
linkages a-(1,6), and 849 cm-1 due to a-configuration 
(Shingel, 2002; Gniewosz, Duszkiewicz-Reinhard, 2008; 
Singh, Saini, 2008; Karim et al., 2009; Cheng, Demirci, 
Catchmark, 2010; Constantin et al., 2011; Bhat et al., 
2012; López-Rubio et al., 2012; Sugumaran et al., 2013).
In the compositions 95:5, 90:10, and 80:20, we 
observed similarities with the spectra of pure EFS that 
were attributable to the high concentration of this base 
polymer. For these same associations, in the 1039 cm-1 
spectrum region, an increase in the band intensity it 
was noticed that was proportional to the addition of the 
polysaccharide, which is likely related to axial symmetric 
bending of the PU’s C-O groups. 
Because of the lack of a shift or appearance of 
new bands, we conclude that only a physical interaction 
exists between the polymers, without the presence of 
intermolecular interactions. 
Thermogravimetric analysis
The results of the TGA are presented in Figure 4. 
The degradation temperatures of EFS and PU were close 
to 400 ºC and 300 ºC, respectively. With regard to the 
associated films, the addition of PU up to 20% caused the 
presence of two distinct degradation steps: one related to 
the polysaccharide and one related to polymethacrylate. 
This finding suggests a physical interaction between the 
chains of the synthetic and natural polymers. Additionally, 
PU presented higher losses of superficial humidity 
compared with the other samples because of its high 
hydrophilicity.
From the first derivative of the TGA (DTG; Figure 5), 
it was noticed that the temperature and speed of maximal 
mass losses for the natural polymer (319 °C) were lower 
than the sample that contained only EFS (410 °C). Karim 
et al. (2009), Constantin et al. (2011), and Teramoto and 
Shibata (2006) found similar degradation values of PU as 
the ones in the present study, thus confirming the correct 
identification of this polysaccharide.
These results suggest that the films based on EFS and 
PU present suitable thermal stability, when considering 
that the process of pellicle coating is performed at 
temperatures of about 40 oC. 
Microstructure characterization by Scanning 
electron microscopy
As shown in Figure 6, dry films showed minor 
changes in morphology. When they were immersed 
in pH 1.2, slight superficial disarrangement due to 
PU hydrophilicity was observed. At pH 6.8, this 
disarrangement was more evident, in which the films 
with 90:10 and 80:20 compositions presented a deeply 
disordered polymer network. This phenomenon may be 
related to the pH-dependent properties of the synthetic 
polymer and structural alterations of the PU network. 
FIGURE 3 - FTIR of polymethacrylate films that contained 
0-20% PU and pure PU.
FIGURE 2 - Swelling index of films after 180 min immersion in 
SGF (pH 1.2) and SIF (pH 6.8) (n=3).
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Mechanical properties
A film coating’s mechanical stability is critical 
for avoiding breaks and providing adequate physical 
protection in pharmaceutical forms. The human organism 
provides several sources of stress for a drug that reaches 
the GIT, such as shear force that results from the motility 
of the upper region and hydrostatic pressure exerted by the 
system against the pellicle after contact with bodily fluids 
(Karrout et al., 2009a; Karrout et al., 2009b).
Table II shows that the film of pure polymethacrylate 
and samples that contained both polymers did not differ 
in terms of the analyzed parameters in the tensile assay 
(p>0.05). Therefore, the addition of the polysaccharide 
did not alter the mechanical characteristics of EFS, 
in which the properties were adequate for coating 
pharmaceutical forms, since it is a product marketed for 
this purpose.
Another important result was the reduction of 
Young’s modulus values, characterizing a polymer 
material with a relative flexibility. Polymers used as 
pharmaceutical coatings must be elastic and flexible to 
be adaptable to the deformations and edges associated 
with pharmaceutical forms without rupturing (Murthy 
Dwibhashyam, Ratna, 2008). 
On the other hand, the film that contained only PU 
showed superior values for all parameters. Because it has 
high hydrophilicity, this polymer presents high amounts 
of intermolecular hydrogen linkages between hydroxyl 
groups, which can justify the higher thresholds of rupture 
tension (Tang et al., 2010). Comparisons between different 
studies are difficult because pellicle preparation and 
methods influence the tensile test results (Macleod, Fell, 
Collett, 1997). However, Xiao, Lim and Tong (2012) and 
Teramoto and Shibata (2006) obtained maximal elongation 
results for PU that were similar to the present results.
CONCLUSION
The nove l  po lymer  mater ia l  p repared  by 
incorporating PU with the polymethacrylate EFS 
presented promising characteristics and properties for 
application in systems destined for enteric drug release. 
It is observed an adequate resistance to GIT fluids; and 
FIGURE 5 - First-derivative TGA of the films with various 
concentrations.
FIGURE 4 - Thermogravimetric analysis of samples of EFS 
100:00 PU, EFS 80:20 PU, and EFS 00:100 PU.
FIGURE 6 - SEM of dry EFS:PU films and after immersion for 
180 min at SGF and SIF (3000x magnification).
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mechanical properties and thermal stability compatible 
with processes required for film coating. The individual 
properties of each polymer in the associations were 
preserved, causing only physical interactions between 
the content of the formulations. The preserved properties 
open up opportunities to exploit the synergism between 
the pH sensitivity properties of polymethacrylate and 
enzyme-dependent properties of PU. In addition, when 
compared with some other polymeric films developed 
with the purpose of enteric release (which use various 
methacrylates:polysaccharides formulations), proved to be 
more resistant to premature release of drugs in the upper 
parts of the GIT. 
These findings suggest that the material obtained 
in the present study has properties that may be applied as 
coatings for colon-specificity. However, complementary 
in vivo and in vitro assays are needed to confirm this 
indication. 
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